Skip to main content
Screener/Healthcare/Biotechnology

PHAR — Pharming Group N.V.

NASDAQ
$12.79+0.79 (+6.58%)
Small CapUnder $20HealthcareLow Beta
$8.69
$21.34
$12.67
$13.09
EPS (TTM)$0.03
P/E Ratio426.33
Dividend Yield—
Market Cap$1.19B
Volume19K
Prev Close$12.00
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$106.4M$5.3M$0.0780.2%5.0%
Q3 '25$97.3M$7.5M$0.1192.7%7.8%
Q2 '25$93.2M$4.7M$0.0790.4%5.0%
Q1 '25$79.1M-$14.7M$-0.2289.5%-18.6%
Q4 '24$92.7M$2.9M$0.0586.8%3.1%
Q3 '24$74.8M-$1.0M$-0.0290.9%-1.4%
Q2 '24$74.0M-$1.2M$-0.0189.2%-1.6%
Q1 '24$55.6M-$12.4M$-0.1584.9%-22.4%
Get Your Daily Market Recap